You're contacting media contact of this press release

Title: VitaOptix Asia Pacific Business Expansion and Otica Brand Launch

Shanghai, China, 15th Jan 2026 - Global AI spectral skin technology company VitaOptix (UK) today announced two strategic milestones: the launch of its Asia-Pacific R&D Center in Shanghai, China, and the opening of its Bangkok Market Operations Center in Thailand. These developments mark the company’s entry into the Southeast Asian market.Alongside this expansion, VitaOptix introduced Otica, a specialized intimate health brand. The brand is scheduled to introduce an AI Intimate Detection System and Pelvic Floor Magnetic Therapy Solution to the Thai market to provide standardized women’s health management options.Infrastructure Development: China R&D Center and Thailand HubThe Shanghai base serves as the first overseas R&D center for VitaOptix, focusing on the development of AI spectral algorithms and clinical validation systems. The facility is staffed by a 30-member interdisciplinary team, including optical engineers, biologists, and AI specialists. Dr. Chen, Head of the Center, stated: “We are adapting the AI spectral technology from our skin analyzers to gynecological detection scenarios to enhance diagnostic precision in the intimate health sector.” The development of the next-generation AI multimodal detection robot, Intima AI Robot, is led by this center and is scheduled for release in 2026.Based in Bangkok, the Thailand Market Operations Center provides localized services and plans to collaborate with medical aesthetics institutions. Dr. Stefan Müller, Founder of VitaOptix, stated: “Thailand’s annual medical tourism revenue exceeds $7 billion. We chose to establish a foothold here due to its mature private healthcare network and open policy environment, making it a strategic pivot to tap into the 600-million-person ASEAN market.”Otica Brand: Integratio...

This press release is issued by King Newswire